While 5-FU primarily exerts its cytotoxic effects by disrupting DNA synthesis and inducing oxidative stress that exceeds a cytotoxic threshold 27 , cancer cells often counteract this oxidative stress by upregulating antioxidant defenses, leading to therapy resistance 10
Preoperative taxol-based chemotherapy (CT) followed by chemoradiation therapy (CTRT) in patients (PTS) with potentially resectable esophageal carcinoma (EC)
[DOI] [PubMed] [Google Scholar] 370.Yi W, Cao R, Chen Z, et al
Annotations for the presence of mobile genetic elements (MGEs) were performed using the mobileOG-db database v1.1.3 130 and integrated into the graphical maps
Peptides that don't require cycling Can use continuously : No tolerance development Use as needed for injuries Can run months continuously for chronic issues No need for breaks Healing peptides generally : Use when needed, stop when healed "Cycling" based on need, not arbitrary timeline Weight loss peptides : Use until goal achieved Transition to maintenance dose Not traditional "cycling" Maintenance doses : Low-dose ongoing use No breaks needed Prevents issue recurrence Peptides where cycling optional Growth hormone peptides : Can run continuously : Many people do Can cycle : 12-16 weeks on, 4 weeks off No evidence required : Personal preference Cycling rationale : Potential tolerance prevention (debated) Cost savings during off periods Mental break from daily injections Continuous use rationale : Maintains consistent benefits Simpler to manage No "restart" period Recommendation : Try 16 weeks continuous first
